Martingale Asset Management L P Reduces Stock Holdings in Encompass Health Co. (NYSE:EHC)

Martingale Asset Management L P lessened its stake in shares of Encompass Health Co. (NYSE:EHC) by 1.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 176,109 shares of the company’s stock after selling 1,925 shares during the quarter. Martingale Asset Management L P owned 0.17% of Encompass Health worth $17,019,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Harbor Capital Advisors Inc. boosted its stake in Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after buying an additional 26,270 shares during the period. QRG Capital Management Inc. boosted its stake in Encompass Health by 85.6% during the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock worth $1,232,000 after buying an additional 6,627 shares during the period. SG Americas Securities LLC purchased a new position in Encompass Health during the second quarter worth about $2,204,000. Los Angeles Capital Management LLC boosted its stake in Encompass Health by 532.4% during the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after buying an additional 42,338 shares during the period. Finally, Deerfield Management Company L.P. Series C purchased a new position in Encompass Health during the second quarter worth about $541,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Down 0.9 %

Shares of NYSE:EHC opened at $102.84 on Friday. The firm’s 50 day moving average price is $97.74 and its 200 day moving average price is $91.19. The stock has a market cap of $10.36 billion, a price-to-earnings ratio of 24.84, a price-to-earnings-growth ratio of 1.36 and a beta of 0.88. Encompass Health Co. has a fifty-two week low of $63.78 and a fifty-two week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the company earned $0.86 earnings per share. The firm’s revenue for the quarter was up 11.9% on a year-over-year basis. As a group, equities research analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. Encompass Health’s payout ratio is currently 16.43%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Barclays increased their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. UBS Group increased their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Stephens reissued an “overweight” rating and set a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. Truist Financial reissued a “buy” rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, Royal Bank of Canada increased their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.